Abbott Laboratories
ABT
A$204.16
Share price
0.10%
Change (1 day)
30.78%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Market capitalization of Abbott Laboratories (ABT)
Market cap: A$355.21 Billion
As of June 2025 Abbott Laboratories has a market cap of A$355.21 Billion. This makes Abbott Laboratories the world's 55th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Abbott Laboratories from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | A$355.21 B | 10.78% |
| 2024 | A$320.65 B | 14.32% |
| 2023 | A$280.47 B | -0.29% |
| 2022 | A$281.30 B | -18.05% |
| 2021 | A$343.27 B | 36.02% |
| 2020 | A$252.37 B | 15.42% |
| 2019 | A$218.65 B | 21.31% |
| 2018 | A$180.25 B | 41.66% |
| 2017 | A$127.23 B | 62.18% |
| 2016 | A$78.45 B | -13.58% |
| 2015 | A$90.78 B | 9.44% |
| 2014 | A$82.95 B | 24.7% |
| 2013 | A$66.52 B | -33.06% |
| 2012 | A$99.37 B | 16.33% |
| 2011 | A$85.42 B | 17.08% |
| 2010 | A$72.96 B | -21.73% |
| 2009 | A$93.22 B | -20.57% |
| 2008 | A$117.37 B | 17.91% |
| 2007 | A$99.54 B | 4.79% |
| 2006 | A$94.98 B | 14.52% |
| 2005 | A$82.94 B | -11.8% |
| 2004 | A$94.04 B | -4.56% |
| 2003 | A$98.54 B | -11.62% |
| 2002 | A$111.49 B | -34.65% |
| 2001 | A$170.61 B | 27.39% |
| 2000 | A$133.93 B | 56.66% |
| 1999 | A$85.48 B | -29.54% |
| 1998 | A$121.32 B | 57.93% |
| 1997 | A$76.81 B | 53.37% |
| 1996 | A$50.08 B |
End of Day market cap according to different sources
On Jun 18th, 2025 the market cap of Abbott Laboratories was reported to be:
A$355.15 Billion
A$355.21 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | A$565.31 B | 59.15% | 🇺🇸 USA |
 Pfizer PFE | A$210.39 B | -40.77% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | A$228.49 B | -35.67% | 🇺🇸 USA |
 Hologic HOLX | A$22.03 B | -93.80% | 🇺🇸 USA |
 Medtronic MDT | A$170.32 B | -52.05% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | A$148.20 B | -58.28% | 🇺🇸 USA |
 Boston Scientific BSX | A$232.06 B | -34.67% | 🇺🇸 USA |
 AstraZeneca AZN | A$350.65 B | -1.28% | 🇬🇧 UK |
 Novartis NVS | A$357.60 B | 0.67% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | A$122.40 B | -65.54% | 🇬🇧 UK |